Dexamed (Dexamfetamine)

Quick links

Choose a section

Quick links to important sections

Advertisements

Dexamed (Dexamfetamine)

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Dexamed (Dexamfetamine)

What is Dexamed (Dexamfetamine)?

Dexamed is a pharmaceutical formulation containing the active substance dexamfetamine sulfate. It belongs to a class of medicines known as central nervous system (CNS) stimulants. Dexamfetamine is the dextrorotatory isomer of the amphetamine molecule, which is primarily utilized for its effects on focus, attention, and impulse control.

Mechanism of Action

As a sympathomimetic amine, Dexamed works by increasing the activity of certain neurotransmitters in the brain, most notably dopamine and noradrenaline. It facilitates the release of these chemicals from storage vesicles in nerve cells and blocks their reuptake into the presynaptic neuron. By increasing the availability of these neurotransmitters in the synaptic cleft, the medication enhances signal transmission in brain regions associated with alertness and executive function.

Clinical Uses

Dexamed is primarily indicated for the management of neurodevelopmental and neurological conditions where central nervous system stimulation is required.

  • Attention Deficit Hyperactivity Disorder (ADHD): In clinical settings, it is used as part of a comprehensive treatment program for ADHD. It helps to improve concentration, reduce distractibility, and stabilize hyperactivity in both pediatric and adult populations when other behavioral interventions have not been sufficient.
  • Narcolepsy: It is also used to treat narcolepsy, a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep. The stimulant properties of dexamfetamine help patients maintain wakefulness throughout the day.

Pharmacological Characteristics

Dexamfetamine is rapidly absorbed following oral administration. It enters the bloodstream and crosses the blood-brain barrier to exert its effects on the central nervous system. The substance is metabolized by the liver and excreted through the kidneys. Because it acts directly on the brain's reward and alertness systems, its use is typically monitored by healthcare professionals to ensure the treatment remains effective and appropriate for the patient's specific needs.

Regulatory References

  1. Dextroamphetamine: MedlinePlus Drug Information
Advertisements

What side effects are possible with Dexamed (Dexamfetamine)?

The official safety profile for Dexamfetamine, as defined in government regulatory documents, is structured around frequently reported adverse reactions and serious warnings across several physiological systems. The most common adverse reactions (incidence equal to or greater than 5%) in adults often affect the Nervous System (insomnia, headache, agitation, anxiety) and the Gastrointestinal system (dry mouth, loss of appetite, nausea, and diarrhea).

Authorities mandate specific warnings regarding the risk of Serious Cardiovascular Events, including reports of sudden death, stroke, and myocardial infarction in adults taking therapeutic doses. Use is therefore strictly contraindicated in patients with pre-existing serious cardiac disease, moderate to severe hypertension, or other symptomatic cardiovascular conditions. Other serious adverse reactions documented in official labeling include the emergence of psychotic or manic symptoms and the risk of a severe reaction known as Serotonin Syndrome when the medication is combined with other serotonergic agents.

Population-specific safety considerations are noted for pediatric patients, where use has been associated with long-term growth suppression (reduced weight and slowing of growth rate). Additionally, the official label states the potential for fetal harm during pregnancy, and therefore, lactation is not recommended while the medication is in use. Certain conditions, such as glaucoma, hyperthyroidism, and agitated states, are listed as absolute contraindications for use.

Advertisements

Overdose and Emergency Response

Dexamfetamine overdose is characterized by severe, acute sympathomimetic effects documented in official regulatory labeling. Manifestations primarily affect the central nervous system and cardiovascular system, signaling a potentially life-threatening event.

Documented clinical presentations of overdose include agitation, extreme restlessness, seizures, hyperreflexia, hallucinations, and progression to coma. Physiological signs include severe hyperthermia (fever), tachyarrhythmias (fast or irregular heartbeat), and fluctuations in blood pressure (hypertension or hypotension).

Official regulatory documents warn that severe overdose can result in fatal outcomes, myocardial infarction (heart attack), cerebral vascular accidents (stroke), rhabdomyolysis, and severe acidosis. These complications define the high-risk nature of acute intoxication.

Because of these severe risks, immediate medical attention must be sought right away if an overdose is suspected. Management is entirely symptomatic and supportive, as no specific antidotes are known for this compound class. Regulatory guidance confirms that procedures may include managing acute agitation with parenteral benzodiazepines and that the drug is not dialyzable. Contacting a poison control center or medical toxicologist is recommended for additional guidance.

Advertisements

Therapeutic Uses of Dexamed (Dexamfetamine)

What Dexamed (Dexamfetamine) Treats: Main Uses and Benefits

Dexamfetamine is commonly used to help manage symptoms that interfere with daily functioning and is relevant when supportive symptom management is appropriate across key therapeutic domains. The medication is indicated as an integral part of a comprehensive treatment program for specific neurological conditions.

The primary therapeutic applications involve addressing symptoms related to heightened neurological activity, specifically in conditions involving recurrent or episodic manifestations. These core indications are Attention-Deficit Hyperactivity Disorder (ADHD) and the chronic sleep disorder Narcolepsy.

The medication is applied in clinical settings marked by pervasive inattention, distractibility, motor restlessness, and pathological excessive daytime sleepiness. These are symptoms that create noticeable physiological strain and disrupt functional stability.

“The primary benefit for patients is the support offered in easing the overall symptom load related to chronic functional deficits, assisting with maintaining stability in routine activities.”


Quick Fact: Relief for Inattention and Sleepiness

Category Symptom Management Focus Patient Benefit
ADHD Inattention, Impulsivity, Restlessness Supports enhanced focus and behavioral regulation.
Narcolepsy Excessive Sleepiness, Somnolence Helps promote sustained functional alertness.
Advertisements

Eligibility and Restrictions for Use

Eligibility and Contraindications for Dexamed (Dexamfetamine)

Official regulatory information outlines specific populations who must not use Dexamfetamine due to significant health risks. This medication is contraindicated for patients with: advanced arteriosclerosis (severe hardening of the arteries), symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, glaucoma, and agitated states. Use is also prohibited in individuals with a history of drug abuse or a known hypersensitivity to sympathomimetic amines.

Critically, Dexamfetamine must not be used concurrently with, or within 14 days following, the administration of a Monoamine Oxidase Inhibitor (MAOI). The product is generally not recommended for children under the age of three years, as safety and efficacy have not been established in this group. While some formulations are approved for children aged six and older, use is often restricted in children and adolescents with known serious structural heart abnormalities due to the risk of serious cardiac events.

Specific advice is given for reproductive health: regulatory sources state that the medicine should not be taken during pregnancy and that women must not breastfeed while using the product, as it passes into breast milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documentation for Dexamfetamine sulfate details specific interaction patterns with other medicines and products.

Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated. This prohibition includes MAOI use within 14 days of starting or stopping dextroamphetamine therapy, due to the established risk of hypertensive crisis and neurotoxic effects.

Pharmacokinetic and Exposure Modification

The systemic exposure of dextroamphetamine is subject to modification by substances that alter pH. Urinary alkalinizing agents (e.g., sodium bicarbonate) are documented to decrease the clearance of the medicine, resulting in higher plasma concentrations. Conversely, agents that acidify the urine (e.g., ascorbic acid, fruit juices) increase its excretion, which officially leads to decreased systemic exposure. The compound is also a substrate for Cytochrome P450 2D6 (CYP2D6), and inhibitors of this enzyme may increase dextroamphetamine exposure.

Pharmacodynamic and Procedural Constraints

Concomitant use with other serotonergic agents (e.g., certain antidepressants or St. John’s Wort) may increase the risk of Serotonin Syndrome. Furthermore, treatment should not be used on the day of surgery involving halogenated narcotics or anaesthetics due to the documented risk of sudden blood pressure increase.

Advertisements

Mechanism of Action

Molecular Action via Neurotransmitter Transporter Reversal

Dexamfetamine (Dextroamphetamine) exerts its primary effect by targeting the Dopamine Transporter (DAT) and the Norepinephrine Transporter (NET). It acts as a substrate, causing the rapid reversal of these transporters, which forces a massive, non-exocytotic surge of dopamine and norepinephrine from the presynaptic neuron directly into the synapse. This mechanism involves active promotion of neurotransmitter efflux, in addition to competitive reuptake inhibition, creating a sudden, high concentration of monoamines.

Cascading Effects on Arousal and Executive Function

The sudden, high synaptic concentration of monoamines leads to sustained activation of postsynaptic Dopamine ( D1/ D2) and Adrenergic (alpha/beta) receptors within the Central Nervous System (CNS). This activity is concentrated in the brain's executive networks (e.g., prefrontal cortex) and arousal pathways. The physiological consequence of this intense, focused signaling is a state characterized by modulation of signaling in circuits governing sustained attention, cognitive control, and neurological vigilance.

️ Mechanism Constraints and Sustained Activity

The efficacy of Dexamfetamine's mechanism is intrinsically linked to the availability of dopamine and norepinephrine stores within the presynaptic nerve endings. Furthermore, chronic activation of the postsynaptic receptors can lead to desensitization or downregulation, resulting in the reduction of the functional physiological response (tachyphylaxis).

Advertisements

Dosage and Administration Information

Dexamfetamine is administered exclusively via the oral route, available in Immediate-Release (IR) tablets, an oral solution, and Extended-Release (ER) capsules. The precise pattern of use is defined by official administration guidelines that govern dosage, frequency, and preparation.

Dosing and Schedule

The treatment regimen involves a phased approach of initiation and dose adjustment. For adults initiating treatment for narcolepsy, the starting quantity is typically 10 mg total per day, given in divided doses. The dosage may be increased by 10 mg/day at weekly intervals up to a usual maximum of 60 mg per day. For ADHD using the IR form, the starting dose is often 5 mg once or twice daily, increasing by a maximum of 5 mg/day at weekly intervals. The first daily dose is taken upon awakening, and administration of the last dose must be timed to avoid interference with sleep.

Administration Conditions

The drug can be taken with or without food, but maintaining a consistent daily schedule is necessary. The ER capsule must be swallowed whole; the capsule or its contents must not be crushed or chewed. However, the internal beads may be sprinkled onto a spoonful of a soft food (such as applesauce) and swallowed immediately as an alternative method. For older adults, treatment is typically initiated at a low dose of 5 mg/day.

Treatment Management

Official protocol mandates that the continued need for the drug, especially beyond 12 months, requires periodic re-evaluation. Furthermore, the protocol suggests considering scheduled treatment interruptions to assess ongoing therapeutic necessity. If a dose is missed, it must be skipped if it is almost time for the next scheduled dose, and patients must not take a double dose.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dexamed (Dexamfetamine)


Evidence for use in Attention-Deficit/Hyperactivity Disorder (ADHD)

Research exploring how Dexamed was evaluated in research involving individuals with ADHD has primarily involved short-term randomized controlled trials, along with observational research. These studies were evaluated in adult and pediatric populations diagnosed with the condition. The research examined outcomes reflecting daily functioning or activity level, as well as symptom intensity, over defined time intervals that were typically short.

Studies monitored how symptoms evolved in the observed populations, and research highlights measurements taken during the study period, particularly in areas related to inattention and hyperactivity. Findings describe patterns observed in these studies, contributing to the broader evidence landscape related to symptom characteristics in the short term. However, the evidence derived from these settings often involves follow-up durations that were limited.


Evidence for use in Narcolepsy

Dexamed was evaluated in research involving individuals with narcolepsy, a condition marked by functional limitations related to excessive daytime sleepiness. These studies were typically small trials and observational reports that research examined in adult and sometimes pediatric populations. The primary measurements focused on outcomes capturing phases of heightened symptom activity, particularly how daytime sleepiness was monitored over time.

Research has explored short-term symptom changes in these populations. The study results reflect the specific conditions under which they were conducted. Findings indicate patterns related to scores on scales measuring sleepiness, which were observed in some studies. This evidence contributes to the broader evidence landscape related to symptom patterns in the context of this condition.


What is Still Uncertain About Dexamed (Dexamfetamine) Research

The broader evidence landscape highlights significant areas of uncertainty. Long-term outcomes are not fully established, and data are still emerging to address questions about sustained use. Comparative evidence—studies directly comparing Dexamed against other established interventions—is often lacking, making comprehensive evidence evaluation challenging. Furthermore, evidence in special populations, such as older adults, adolescents, and populations related to pregnancy and breastfeeding, remains insufficient compared to the primary study populations.

Key Studies & References

  1. National Institute for Health and Care Excellence (NICE): Attention deficit hyperactivity disorder: diagnosis and management (NG87)
  2. Practice guideline for the treatment of patients with narcolepsy and other hypersomnias of central origin
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Dexamed (Dexamfetamine) (FAQ)


Q: How long after taking a dose of Dexamed does a person usually feel the effects start working?

A: According to official product information, immediate-release (IR) formulations typically begin to take effect in approximately 0.5 to 1.5 hours. Extended-release (ER) formulations may take slightly longer to reach their effective concentration, usually around 1.5 to 2 hours.

Q: How long do the therapeutic effects of a single dose of immediate-release Dexamed typically last?

A: Regulatory information indicates that the therapeutic effects of a single dose of the immediate-release (IR) formulation generally last for an estimated period of 3 to 6 hours.

Q: Is there a risk of developing a tolerance to Dexamed over time with regular use?

A: Official labeling discusses the potential for the body to develop both dependence and tolerance over time, particularly with chronic use. Tolerance refers to a gradual loss of the initial response to the same dosage over time.

Q: What are the signs that a person might be experiencing withdrawal symptoms after stopping Dexamed?

A: Regulatory documents state that abrupt cessation or significant reduction of the dose can lead to withdrawal symptoms. These effects may include extreme fatigue, depressed mood, and sleep disturbances such as hypersomnia (excessive sleeping).

Q: Is it normal to experience a 'crash' or rebound effect when Dexamed wears off?

A: While 'crash' is a non-clinical term, official adverse reaction reports detail potential effects as the medicine wears off or during withdrawal. These effects may include feelings of dysphoria (a state of unease), fatigue, or depression.

Q: What are the possible psychiatric side effects, such as changes in mood or behaviour, that users should monitor?

A: The official labeling documents various psychiatric side effects, including restlessness, irritability, euphoria, dysphoria, aggression, and anger. Patients should also be monitored for the emergence of new or worsened psychotic or manic symptoms.

Q: Is Dexamed safe for use by adults, or is it primarily prescribed for children and adolescents with ADHD?

A: Dexamfetamine is officially approved and indicated for use in both pediatric patients (children and adolescents) and adults for its indicated conditions. Dosing guidelines are established for both populations.

Q: Are there special considerations for older adults (65 and over) taking Dexamed?

A: Regulatory texts advise special consideration for older adults due to their potential increased sensitivity to the medicine's effects. Treatment is typically initiated at a lower daily dose.

Q: What are the signs of a possible allergic reaction to Dexamed?

A: Documented allergic reactions include skin-related issues such as rash and hives (urticaria). Patients should also be aware of the potential for more severe hypersensitivity reactions like angioedema (swelling beneath the skin) and anaphylaxis.

Q: What should a patient do if they accidentally miss a dose of Dexamed?

A: Official protocol advises that if a dose is missed, it should be skipped if it is almost time for the next scheduled dose. Product information advises against taking a double dose to compensate for the missed one.

Q: Can Dexamed affect a person's ability to drive or operate heavy machinery?

A: Yes, due to the potential for side effects that affect the central nervous system, such as dizziness and blurred vision, patients are warned that the medicine may impair their ability to operate machinery or drive safely.

Q: How can parents monitor if Dexamed is working effectively for their child's ADHD symptoms?

A: The drug is indicated to modulate core ADHD symptoms like inattention and hyperactivity, which are the focus of therapeutic monitoring. Official guidelines mandate that the need for continued treatment be checked through periodic re-evaluation by a healthcare professional.

Q: Do extended-release forms of Dexamfetamine have a different side effect profile than immediate-release Dexamed?

A: Official regulatory reviews note that clinical comparisons between immediate-release (IR) and extended-release (ER) forms have not demonstrated consistent or significant differences in their overall side effect profiles.

Q: Is it normal to have some slight changes in heart rate when first starting Dexamed?

A: Yes, the official labeling documents that changes in heart rate, specifically tachycardia (increased heart rate), are known cardiovascular adverse reactions that can occur, especially when starting treatment.

Q: Can Dexamed cause skin-related issues, such as a rash or hives?

A: Skin-related issues such as rash and hives (urticaria) are documented as possible allergic adverse reactions associated with the use of the medicine.

Q: What is the risk of developing a severe but rare condition like Serotonin Syndrome when taking Dexamed?

A: Serotonin Syndrome is listed in regulatory warnings as a potentially life-threatening reaction. This risk is primarily associated with using Dexamed alongside other medicines that affect the serotonin system.

Q: Does Dexamed have a different brand name in other countries, and what are they?

A: Yes, dextroamphetamine is the active ingredient and is known by various brand names globally. For example, regulatory texts reference brand names like Dexedrine in different regions.

Q: Can Dexamed affect sexual function or libido?

A: Yes, official adverse reaction reports include changes in libido (sex drive) and impotence (erectile dysfunction) as possible side effects.

Q: Can Dexamed be used safely in patients who also have a history of seizures or epilepsy?

A: Regulatory warnings state that the medicine may lower the convulsive threshold. The potential to lower the convulsive threshold is an important safety consideration for patients with a history of seizures.

Q: Does the efficacy of Dexamed change as a person gets older?

A: The necessity of recommending lower starting doses for older adults suggests that a person's response to the medicine, or their sensitivity to its effects, may change with age.

Q: Can Dexamed interact with herbal supplements or vitamins?

A: Yes, the regulatory information notes specific interactions with certain supplements. For example, herbal supplements like St. John’s Wort and vitamins like Ascorbic Acid (Vitamin C) can potentially affect the medicine's absorption or efficacy.

Q: Is a change in vision, like blurred vision, a possible side effect of Dexamed?

A: Yes, blurred vision and difficulties with accommodation (the eye's ability to focus) are documented as possible side effects under the official adverse reactions list for eye disorders.

Q: Is there any known interaction between Dexamed and alcohol consumption?

A: Official drug interaction information suggests that combining dextroamphetamine with alcohol may increase the risk of cardiovascular side effects, such as changes in blood pressure or heart rate.

Q: Is it necessary to have regular medical check-ups, like blood pressure and heart rate monitoring, while taking Dexamed?

A: Regulatory warnings indicate that patients require monitoring at appropriate intervals for potential cardiovascular changes, such as increased heart rate (tachycardia) and high blood pressure (hypertension).

Q: What symptoms indicate a possible serious heart problem while taking Dexamed?

A: Patients should be alert for symptoms that may indicate a serious cardiovascular problem. These documented symptoms include chest pain, shortness of breath, or unexplained fainting (syncope) during treatment.

Q: Are there any long-term effects on the liver or kidneys from taking Dexamed?

A: The medicine is processed by the liver and eliminated by the kidneys. Regulatory information notes that pre-existing liver or kidney dysfunction could inhibit the elimination of the medicine from the body.

Q: Is Dexamed considered a short-acting or long-acting stimulant medication?

A: The medicine is available in two main forms. The immediate-release (IR) tablets are considered short-acting, while the extended-release (ER) capsules are designed to provide a longer duration of activity.

Q: What are the most common side effects reported by users who take Dexamed regularly?

A: The most common adverse reactions reported in official documents (occurring in 5% or more of patients) include dry mouth, loss of appetite, insomnia, headache, weight loss, nausea, and feelings of anxiety or agitation.

Q: Can taking Dexamed cause or worsen anxiety or nervousness in some people?

A: Yes, anxiety and agitation are documented adverse reactions. Furthermore, the medicine is contraindicated (should not be used) in patients who already have severe anxiety or agitated states, as it may worsen these symptoms.

Q: Is a decreased appetite a common side effect, and does it usually improve with time?

A: Loss of appetite is a common side effect of the medicine. The official labeling notes that this effect may lead to weight loss in some patients.

Q: Can Dexamed affect a child's growth or weight gain over a long period of treatment?

A: Yes, the regulatory warnings for pediatric patients advise that long-term use has been associated with the potential for long-term suppression of growth, including both reduced height and weight.

Q: Do certain foods or drinks, such as acidic juices, affect how well Dexamed is absorbed or works?

A: Official drug interaction information states that gastrointestinal acidifying agents, such as certain fruit juices and ascorbic acid (Vitamin C), can lower the absorption of the medicine. This reduction in absorption could potentially reduce its effectiveness.

Q: Can Dexamed cause issues like dry mouth, and what can be done to manage this side effect?

A: Dry mouth is listed as a common side effect in the official adverse reactions list. While the regulatory documents confirm its occurrence, they do not typically provide specific advice on managing the side effect.

Q: What specific monitoring is required for children and young people taking Dexamed?

A: Official guidelines advise that children and young people require close monitoring, particularly for potential growth suppression. This includes regular checks of height and weight, in addition to heart rate and blood pressure monitoring.

Advertisements

How should Dexamed (Dexamfetamine) be stored and disposed of?

Storage and Disposal Requirements

Official regulatory labeling for Dexamfetamine (Dextroamphetamine Sulfate) defines mandatory conditions for storage and disposal to ensure product integrity and secure handling.

Storage Conditions

Dexamfetamine must be stored at controlled room temperature, specifically between 20^circ to 25 C (68^circ to 77 F). The product must be stored in a safe place, preferably locked, and kept out of the reach of children due to its status as a controlled substance. Some liquid forms require a light-resistant container. Patients are explicitly instructed not to give the medicine to anyone else.

Disposal and Handling

Disposal of unused or expired medicine must comply with local requirements. For unused product, the FDA advises using an authorized drug take-back program. If a take-back program is unavailable, the medicine should be mixed with an unappealing substance and sealed before being placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dexamed (Dexamfetamine) found in:

A-Z Index: